Year archive

InnoCare Pharma Limited — 2025 filings

All 67 regulatory filings released by InnoCare Pharma Limited (9969) in 2025, sourced directly from the official regulator.

67 Filings

2025 Period

2025 filings (67)

Filing	Released	Lang
GRANT OF RESTRICTED SHARE UNITS PURSUANT TO 2023 SHARE AWARD SCHEME Share Issue/Capital Change	2025-12-31	English
VOLUNTARY ANNOUNCEMENT - POSITIVE PHASE IIB CLINICAL TRIAL RESULTS OF ORELABRUTINIB IN SYSTEMIC LUPUS ERYTHEMATOSUS AND PHASE III CLINICAL TRIAL INITIATION Regulatory Filings	2025-12-14	English
INSIDE INFORMATION ANNOUNCEMENT - APPROVAL OF ZURLETRECTINIB FOR THE TREATMENT OF ADULT AND ADOLESCENT PATIENTS WITH SOLID TUMORS HARBORING NTRK GENE FUSIONS IN CHINA Regulatory Filings	2025-12-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-04	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-11-13	English
(1) 2025 QUARTERLY REPORT FOR THE THIRD QUARTER AND (2) CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE Interim / Quarterly Report Q3 2025	2025-11-13	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-05	English
DATE OF BOARD MEETING Regulatory Filings	2025-10-31	English
Next Day Disclosure Return Transaction in Own Shares	2025-10-10	English
INSIDE INFORMATION ANNOUNCEMENT - GLOBAL STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH ZENAS BIOPHARMA Regulatory Filings	2025-10-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Share Issue/Capital Change	2025-10-06	English
INTERIM REPORT 2025 Interim / Quarterly Report H1 2025	2025-09-22	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-02	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-20	English
GRANT OF RESTRICTED SHARE UNITS PURSUANT TO 2023 SHARE AWARD SCHEME Share Issue/Capital Change	2025-08-20	English
GRANT OF RESTRICTED SHARES PURSUANT TO 2024 RMB SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-08-20	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-19	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H2 2025	2025-08-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-05	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-05	English
Next Day Disclosure Return - Changes in Issued Share Capital Share Issue/Capital Change	2025-07-18	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-07-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-03	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-06-20	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 20 JUNE 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-20	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-06-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-04	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-29	English
INSIDE INFORMATION ANNOUNCEMENT - APPROVAL OF MINJUVI (TAFASITAMAB) IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN CH Regulatory Filings	2025-05-21	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-16	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-13	English
2025 QUARTERLY REPORT FOR THE FIRST QUARTER Interim / Quarterly Report Q1 2025	2025-05-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-07	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-06	English
DATE OF BOARD MEETING Report Publication Announcement	2025-04-28	English
FORM OF PROXY FOR ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-28	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-28	English
(1) 2024 ANNUAL REPORT; (2) 2024 WORK REPORT OF THE BOARD OF DIRECTORS; (3) PROFIT DISTRIBUTION PLAN OF THE COMPANY IN 2024; (4) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE S Proxy Solicitation & Information Statement	2025-04-28	English
ESG Report 2024 Environmental & Social Information	2025-04-28	English
Annual Report 2024 Regulatory Filings	2025-04-28	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF ORELABRUTINIB FOR THE FIRST-LINE TREATMENT OF CLL/SLL IN CHINA Regulatory Filings	2025-04-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-15	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-03	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-27	English
Terms of Reference for the Nomination Committee Governance Information	2025-03-27	English
UPDATE IN USE OF PROCEEDS OF RMB SHARE ISSUE Capital/Financing Update	2025-03-27	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 Regulatory Filings	2025-03-27	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-20	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-14	English
VOLUNTARY ANNOUNCEMENT - LATE-BREAKING ORAL PRESENTATION OF ICP-488 PHASE II CLINICAL DATA FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS AT 2025 AAD ANNUAL MEETING Regulatory Filings	2025-03-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-05	English
VOLUNTARY ANNOUNCEMENT - ABSTRACT AND POSTER PRESENTATION OF ORELABRUTINIB PHASE II CLINICAL DATA FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS AT ACTRIMS 2025 Regulatory Filings	2025-02-26	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF REGISTRATIONAL PHASE III STUDY OF BCL2 INHIBITOR ICP-248 (MESUTOCLAX) IN COMBINATION WITH ORELABRUTINIB AS FIRST-LINE THERAPY FOR TREATMENT OF CLL/SLL PATIENT Regulatory Filings	2025-02-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-06	English
Next Day Disclosure Return Transaction in Own Shares	2025-01-24	English
Next Day Disclosure Return Transaction in Own Shares	2025-01-23	English
Next Day Disclosure Return Transaction in Own Shares	2025-01-22	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-01-21	English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR Board/Management Information	2025-01-21	English
VOLUNTARY ANNOUNCEMENT - LICENSE AGREEMENT WITH PROLIUM FOR THE DEVELOPMENT AND COMMERCIALIZATION OF ICP-B02 (CM355) Regulatory Filings	2025-01-20	English
ANNOUNCEMENT IN RELATION TO THE ESTIMATED ANNUAL RESULTS FOR 2024 Earnings Release FY 2024	2025-01-16	English
GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 3.10(1) and 3.11 OF THE LISTING RULES Board/Management Information	2025-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Share Issue/Capital Change	2025-01-03	English

Filings by year

2026 31 filings
2025 67 filings
2024 83 filings
2023 77 filings
2022 85 filings
2021 49 filings
2020 37 filings
2019 2 filings